Adrenaline autoinjectors

Search documents
ALK upgrades its full-year revenue outlook
Globenewswireยท 2025-08-12 12:45
Inside information ALK (ALKB:DC / OMX: ALK B) today announced that the 2025 full-year financial outlook has been upgraded. Revenue is now expected to grow by 12-14% in local currencies (previously 9-13% growth). The operating profit (EBIT) margin is still expected to improve by 5 percentage points to 25%. The updated outlook reflects higher-than-expected revenue in Europe in Q2 and an improved outlook for the rest of the year. Q2 was positively influenced by sales of adrenaline autoinjectors and by the m ...